Skip to search.
 FTSE 100 Down 1.27%

Kite Pharma, Inc. (KITE)

-NasdaqGS
46.50 Down 0.11(0.24%) 16:59 - Nasdaq Real Time Price
Prev Close:46.61
Open:46.56
Bid:46.03 x 100
Ask:46.15 x 200
1y Target Est:78.27
Beta:N/A
Earnings Date:13 May - 17 May (Est.)
Day's Range:45.86 - 47.63
52wk Range:38.41 - 89.84
Volume:168,618
Avg Vol (3m):1,110,810
Market Cap:2.33b
P/E (ttm):N/A
EPS (ttm):-2.33
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

  • No Headlines available for KITE at this time.

Comparison

Symbol% ChgMkt Cap
KITEDown 0.24%2.33b
PFEDown 1.15%201.42b
CELGDown 4.71%80.47b

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):131.45
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-5.43
Quarterly EPS Est (Mar-16) :-1.09
Mean Recommendation*:1.5
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Kite Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel cancer immunotherapy products. more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback